Production professionalism: With more than 20 years of experience in peptide production, we ensure the stability and reliability of the quality of each batch of peptides. Each batch of products has a corresponding quality inspection report.

Products cover areas such as immunity, gastrointestinal tract, antiviral, obstetrics and gynecology, diabetes, cardiovascular and cerebrovascular diseases, rare diseases, orthopedics, etc. where peptide drugs play an important role. The company's peptide preparation products, enfuvirtide and carbetocin injection for injection, are the first generic peptide drugs in China; bivalirudin, liraglutide, thymomethasin, icatibant, enfuvirtide, etc. are synthesized More difficult generic APIs have been exported to international markets such as Europe, the United States, India, and South Korea. End customers include Fresenius, Aurobindo, Mylan, Lupin, and Xinxin. Well-known domestic and foreign pharmaceutical companies such as Litai, Shanghai Pharmaceuticals First Biochemical, and Yangtze River; the industrialized research and development of five varieties of atosiban acetate, octreotide acetate, somatostatin, thymomethasin and carbetocin are included in the "' The 11th Five-Year Plan's National Major New Drug Creation Project"; the two preparation varieties of icatibant and posaconazole that the company has submitted for drug registration have been included in the "First Batch of Encouraged Generic Drugs Catalog" by the National Health Commission.